Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?

BACKGROUND: Amyloid-β positron emission tomography (PET) and cerebrospinal fluid (CSF) Aβ(42) are considered interchangeable for clinical diagnosis of Alzheimer’s disease. OBJECTIVE: To explore the clinical reasoning for requesting additional amyloid-β PET after performing CSF biomarkers. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimand, Juhan, Groot, Colin, Teunissen, Charlotte E., Windhorst, Albert D., Boellaard, Ronald, Barkhof, Frederik, Nazarenko, Sergei, van der Flier, Wiesje M., van Berckel, Bart N.M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081099/
https://www.ncbi.nlm.nih.gov/pubmed/31796674
http://dx.doi.org/10.3233/JAD-190836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081099/
https://www.ncbi.nlm.nih.gov/pubmed/31796674
http://dx.doi.org/10.3233/JAD-190836

Ejemplares similares